ICIS Chemicals and the economy
The escalating cost of developing blockbuster drugs has led big pharma to forge several risk-sharing ventures THE ROAD to developing a...
Many chemical players in mature markets see value-added products as vital to compete against low-cost commodities from Asia and the Middle East FOR...
Cereplast sees a stronger 2010 after a major facelift. Will demand for its bio-resins catch on? MOLDING A successful bioplastic company in the...
LANXESS' Dr. Werner Breuers on Innovation View more presentations from jchangiii99. LANXESS board member Werner Breuers urges keeping...
Legal, regulatory and societal forces present a growing risk to successful products. How should management respond? Consultant's cornerRonald...
Despite its forests, North America is not the paper maker it once was. But globally, increased sustainability should lead to further growth THE...
Insight
INSIGHT: Lyondell's path out of bankruptcy rests on Feb hearings "One court document implies a mid-year exit, based on a 20 May deadline to have the court confirm its reorganisation plan." more
VIDEO – ICIS news Americas Lunchtime Bulletin 9 February 2010 More...